References
Meerwijk EL, Sevelius JM. Transgender population size in the united states: a meta-regression of population-based probability samples. Am J Public Health. 2017;107(2):e1–8. https://doi.org/10.2105/AJPH.2016.303578.
Clarke CN, Cortina CS, Fayanju OM, Dossett LA, Johnston FM, Wong SL. Breast cancer risk and screening in transgender persons: a call for inclusive care. Ann Surg Oncol. 2022;29(4):2176–80. https://doi.org/10.1245/s10434-021-10217-5.
Cortina CS. Inclusion and reporting of transgender and nonbinary persons in clinical trials and tumor registries—the time is now. JAMA Oncol. 2022;8(8):1097–8. https://doi.org/10.1001/jamaoncol.2022.1638.
de Blok CJM, Wiepjes CM, Nota NM, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ. 2019;365:1652. https://doi.org/10.1136/bmj.1652.
Ray A, Fernstrum A, Mahran A, Thirumavalavan N. Testosterone therapy and risk of breast cancer development: a systematic review. Curr Opin Urol. 2020;30(3):340–8. https://doi.org/10.1097/MOU.0000000000000763.
Morrow M, Newman LA. Disparities in cancer care: educational initiatives. Ann Surg Oncol. 2022;29(4):2136–7. https://doi.org/10.1245/s10434-021-11095-7.
Funding
No funding support to report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no relevant disclosures to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Martinez, E.O., Rubin, M., Miller, T. et al. Transgender and Non-binary Persons in Contemporary Oncology Randomized Clinical Trials. Ann Surg Oncol 29, 7958–7960 (2022). https://doi.org/10.1245/s10434-022-12418-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12418-y